Clinical trial
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed…
NCT00074100 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00074100 |
|---|---|
| Title | Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy |
| Official title | Amonafide: Individual Phenotype-Adjusted Chemotherapy for Women With Metastatic Breast Cancer Who Have Progressed Despite Prior Chemotherapy |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | amonafide dihydrochloride |
| Start date | Aug 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Dec 11, 2003 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: